3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioma
2
Glioblastoma
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Resectable Lung Non-Small Cell Carcinoma
1
Radiation Injuries
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Lymphoma, T-Cell, Peripheral
1
Lung Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Frailty
1
Chordoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Astrocytoma
1
Interventions
Radiotherapy
12
Amifostine
7
Cisplatin
6
Etoposide
3
Carboplatin
3
Bevacizumab
3
Radiotherapy, Intensity-Modulated
2
Radiation
2
Paclitaxel
2
Heavy Ion Radiotherapy
2
Fluorouracil
2
sargramostim
1
lithium sulfate
1
Vincristine
1
Surgical Procedures, Operative
1
Steroids
1
Selenomethionine
1
Rituximab
1
Protons
1
Proton Therapy
1
Procarbazine
1
Physical Therapy Modalities
1
Photons
1
Palonosetron
1
Olanzapine
1
Methylprednisolone
1
Methotrexate
1
Mental Status and Dementia Tests
1
Melatonin
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Radiation Injuries
×
Protons
×
Clear all
NCT05548504
2022-09-21
HERAN2
Odense University Hospital
Phase 2
Not yet recruiting
182 enrolled